Evidence map›Paper›PMID 35314781›Full record

ArticleNature microbiology2022

Microbial communities form rich extracellular metabolomes that foster metabolic interactions and promote drug tolerance.

Jason S L Yu, Clara Correia-Melo, Francisco Zorrilla, Lucia Herrera-Dominguez, Mary Y Wu, Johannes Hartl, Kate Campbell, Sonja Blasche, Marco Kreidl, Anna-Sophia Egger and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Nature microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 125 citations in OpenAlex.

  1. Pooled it
  2. Enhanced Endophytic Colonization of Flavobacterium Promotes Plant Resistance to Fusarium Wilt.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Cross-feeding enables robust coexistence between four bacterial species.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Pyocyanin produced byAntimicrobial agents and chemotherapy · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 4 countries.

Jason S L Yu *The Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-5203-3603
Clara Correia-Melo *The Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-6062-1472
Francisco ZorrillaMedical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK.
Lucia Herrera-DominguezThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-8276-2241
Mary Y WuHigh-Throughput Screening, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-2074-6171
Johannes HartlDepartment of Biochemistry, Charité University Medicine, Berlin, Germany.ORCID http://orcid.org/0000-0001-8470-5355
Kate CampbellDepartment of Biochemistry, University of Cambridge, Cambridge, UK.
Sonja BlascheMedical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK.
Marco KreidlThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.
Anna-Sophia EggerThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-5204-7121
Christoph B MessnerThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.
Vadim DemichevThe Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK.
Anja FreiwaldDepartment of Biochemistry, Charité University Medicine, Berlin, Germany.
Michael MüllederCore Facility - High Throughput Mass Spectrometry, Charité University Medicine, Berlin, Germany.
Michael HowellHigh-Throughput Screening, The Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0003-0912-0079
Judith BermanShmunis School of Biomedical and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Israel.ORCID http://orcid.org/0000-0002-8577-0084
Kiran R PatilMedical Research Council Toxicology Unit, University of Cambridge, Cambridge, UK.
Mohammad Tauqeer Alam *Department of Biology, College of Science, United Arab Emirates University, Al-Ain, UAE. mtalam@uaeu.ac.ae.ORCID http://orcid.org/0000-0002-6872-0691
Markus Ralser *The Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London, UK. markus.ralser@charite.de.ORCID http://orcid.org/0000-0001-9535-7413
The Francis Crick Institute · GBUniversity of Cambridge · GBCharité - Universitätsmedizin Berlin · DETel Aviv University · ILUnited Arab Emirates University · AE

Funding

Cancer Research UK FC001134Medical Research Council FC001134Medical Research Council MC_UU_00025/11Wellcome Trust 200829/Z/16/ZWellcome Trust FC001134
6 · The paper itself

Abstract

Microbial communities are composed of cells of varying metabolic capacity, and regularly include auxotrophs that lack essential metabolic pathways. Through analysis of auxotrophs for amino acid biosynthesis pathways in microbiome data derived from >12,000 natural microbial communities obtained as part of the Earth Microbiome Project (EMP), and study of auxotrophic-prototrophic interactions in self-establishing metabolically cooperating yeast communities (SeMeCos), we reveal a metabolically imprinted mechanism that links the presence of auxotrophs to an increase in metabolic interactions and gains in antimicrobial drug tolerance. As a consequence of the metabolic adaptations necessary to uptake specific metabolites, auxotrophs obtain altered metabolic flux distributions, export more metabolites and, in this way, enrich community environments in metabolites. Moreover, increased efflux activities reduce intracellular drug concentrations, allowing cells to grow in the presence of drug levels above minimal inhibitory concentrations. For example, we show that the antifungal action of azoles is greatly diminished in yeast cells that uptake metabolites from a metabolically enriched environment. Our results hence provide a mechanism that explains why cells are more robust to drug exposure when they interact metabolically.

Indexed as

Microbial InteractionsMicrobiotaDrug ToleranceMetabolic Networks and PathwaysMetabolome

Identifiers

PMID35314781
PMCPMC8975748
OpenAlexW4220986765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.